Bank of America
BCYC

Bank of America’s Bicycle Therapeutics BCYC Stock Holding History

Bank of America’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-96,401
Closed -$683K – 5812
2025
Q4 		$683K Sell
96,401
-495,134
-84% -$3.65M ﹤0.01% 4734
2025
Q3 		$4.58M Sell
591,535
-239,099
-29% -$1.8M ﹤0.01% 4096
2025
Q2 		$5.77M Buy
830,634
+267,075
+47% +$2.13M ﹤0.01% 3752
2025
Q1 		$4.78M Buy
563,559
+170,700
+43% +$2.01M ﹤0.01% 3845
2024
Q4 		$5.5M Buy
392,859
+7,994
+2% +$171K ﹤0.01% 3499
2024
Q3 		$8.71M Buy
384,865
+1,061
+0.3% +$24.5K ﹤0.01% 3204
2024
Q2 		$7.77M Sell
383,804
-13,008
-3% -$294K ﹤0.01% 3198
2024
Q1 		$9.88M Sell
396,812
-64,519
-14% -$1.37M ﹤0.01% 2991
2023
Q4 		$8.34M Buy
461,331
+455,035
+7,227% +$7.53M ﹤0.01% 3076
2023
Q3 		$126K Sell
6,296
-236
-4% -$5.4K ﹤0.01% 6142
2023
Q2 		$167K Buy
6,532
+613
+10% +$14.2K ﹤0.01% 5956
2023
Q1 		$126K Buy
5,919
+406
+7% +$10.2K ﹤0.01% 6156
2022
Q4 		$163K Sell
5,513
-3,613
-40% -$96.9K ﹤0.01% 6020
2022
Q3 		$212K Sell
9,126
-8,171
-47% -$194K ﹤0.01% 5938
2022
Q2 		$290K Buy
17,297
+14,187
+456% +$299K ﹤0.01% 5832
2022
Q1 		$136K Buy
3,110
+586
+23% +$27.4K ﹤0.01% 6696
2021
Q4 		$153K Buy
2,524
+368
+17% +$20.3K ﹤0.01% 6645
2021
Q3 		$90K Sell
2,156
-176
-8% -$6.16K ﹤0.01% 6773
2021
Q2 		$71K Buy
2,332
+1,269
+119% +$38.3K ﹤0.01% 6677
2021
Q1 		$31K Buy
1,063
+847
+392% +$21.8K ﹤0.01% 6768
2020
Q4 		$4K Buy
+216
New +$4.17K ﹤0.01% 6847

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America's BCYC Position: Q1 2026 in Review

Bank of America sold out of Bicycle Therapeutics (BCYC) in Q1 2026, closing a stake of 96,401 shares — an estimated $683K sold.

Bank of America first reported a position in BCYC in Q4 2020 and held it in 21 quarters. The position peaked at $9.88M in Q1 2024. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Bank of America reported no remaining Bicycle Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 96,401 Bicycle Therapeutics shares in Q1 2026, an estimated $683K.
  • Bank of America first reported a position in Bicycle Therapeutics in Q4 2020 and held it in 21 quarters.
  • Bank of America's Bicycle Therapeutics position peaked at $9.88M in Q1 2024.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.